Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseasesRebecca Ferrisi, Francesca Gado, Clementina Manera et al.|Pharmacological Research|2021Cited by 20
Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint StressHye Ji J. Kim, Robert B. Laprairie, Ayat Zagzoog et al.|Brain Sciences|2023Cited by 6
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulatorsFrancesca Gado, Gabriella Ortore, Costanza Ceni et al.|European Journal of Pharmaceutical Sciences|2021Cited by 5